Work With Your Doctor to Get Zanzalintinib (XL092) Covered by Aetna in New York: Provider Partnership Guide
Answer Box: Your Partnership Path to Coverage
Zanzalintinib (XL092) requires close collaboration with your oncologist since it's investigational and only available through Exelixis's compassionate use program or clinical trials. In New York, your fastest path involves: (1) Your doctor submitting FDA Form 3926 for expanded access,